| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T96 |
0-407 |
Sentence |
denotes |
The current study, as well as an earlier study that tested 21 IVIG lots (9 Gamunex C, 10 Gammagard Liquid, 2 other) with a SARS-CoV-2-specific enzyme-linked immunosorbent assay (ELISA; receptor-binding domain or spike protein) that was shown to correlate well with a neutralization test [14] revealed the absence of cross-reactive antibodies against SARS-CoV-2 in IVIG lots produced from prepandemic plasma. |
| T97 |
408-511 |
Sentence |
denotes |
Currently available IVIGs can therefore not be expected to afford protection from SARS-CoV-2 infection. |
| T98 |
512-787 |
Sentence |
denotes |
Nevertheless, several clinical trials currently investigate IVIG at high dosage in the treatment of COVID-19 patients (clinicaltrials.gov), with the expected benefit attributable to the anti-inflammatory and immunomodulatory capacity of IVIG, rather than an antiviral effect. |
